key: cord-0278655-kh7445kz
authors: Lu, Feiyu; Wang, Shengnan; Wang, Ying; Yao, Yunpeng; Wang, Yangeng; Liu, Shujun; Wang, Yangyang; Yu, Yongli; Wang, Liying
title: Conserved T-cell epitopes predicted by bioinformatics in SARS-COV-2 variants
date: 2021-08-13
journal: bioRxiv
DOI: 10.1101/2021.08.12.456182
sha: 438841f41e1fe9dee573d7231e01f39c9fee8d05
doc_id: 278655
cord_uid: kh7445kz

Background Finding conservative T cell epitopes in the proteome of numerous variants of SARS-COV-2 is required to develop T cell activating SARS-COV-2 capable of inducing T cell responses against SARS-COV-2 variants. Methods A computational workflow was performed to find HLA restricted CD8+ and CD4+ T cell epitopes among conserved amino acid sequences across the proteome of 474727 SARS-CoV-2 strains. Results A batch of covserved regions in the amino acid sequences were found in the proteome of the SARS-COV-2 strains. 2852 and 847 peptides were predicted to have high binding affinity to distint HLA class I and class II molecules. Among them, 1456 and 484 peptides are antigenic. 392 and 111 of the antigenic peptides were found in the conseved amino acid sequences. Among the antigenic-conserved peptides, 6 CD8+ T cell epitopes and 7 CD4+ T cell epitopes were identifed. The T cell epitopes could be presented to T cells by high-affinity HLA molecules which are encoded by the HLA alleles with high population coverage. Conclusions The T cell epitopes are conservative, antigenic and HLA presentable, and could be constructed into SARS-COV-2 vaccines for inducing protective T cell immunity against SARS-COV-2 and their variants.

HLA class I molecules, expressed by cores of nanomolar IC50 and percentile rank 138 respectively. Thresholds for high binding affinity were set ≤500 nM and strong binding 139 strength were set at top 0.5%. The NetMHCIIPan 4.0 server (29) was used to predict the 140 binding affinity and binding strength of the peptides (15 mer) across the proteome of the 141 SARS-COV-2 (NC_045512.2) to the selected HLA class II molecules (Table S2) . 142 Thresholds for high binding affinity were set ≤500 nM and strong binding strength were 143 set at top 1%. The antigenicity of screened peptides to both HLA class I and class II 144 molecules was predicted using Vaxijen-2.0 (30, 31), which analyzed higher order 145 interactions positions of protein sequence and exploiting the physicochemical properties 146 (hydrophobicity, molecular size, polarity) of amino acids. Each of the peptides was 147 scored for selecting. The peptides with the scores above 0.4 were determined antigenecity. The spacial structure of HLA molecules were downloaded from pHLA database (34) . 158 Docking simulations between predicted CD8 + T cell epitopes or CD4 + T cell epitopes and 159 presented HLA molecules were performed using the GalaxyPepDock server (35), which 160 enables prediction of 3D protein-peptide complex structure interactions from input 161 protein structure and peptide sequence using similar interactions found in the structure Next, we screened and predicted T cell epitopes in the repertoire of the SARS-COV-2 proteome. As for the CD8 + T cell epitopes, using NetMHCpan 4.1 server (29), we 196 screened the 9-mer peptides across the proteome of the SARS-COV-2 (NC_045512.2) for 197 their binding affinity with distinct HLA class I molecules encoded by 27 HLA class I 198 alleles (Table S2 ). The alleles account for the population coverage > 97% worldwide (24).

Based on more than 850,000 quantitative binding affinity and mass-spectrometry eluted (Table S2 ) encoded by the elleles which account for the 209 population coverage >99% (25). Resultantly, 847 candidate HLA class II binding 210 peptides from the SARS-COV-2 proteome were predicted to have high binding affinity (≤ 211 500 nM) and strong binding strength (percentile rank ≤1%).

Furthermore, we predicted wheather these candidate peptides paired with distinct 213 HLA molecules could efficiently bind T cell recepters (TCR) by analysing 214 hydrophobicity, molecular size, polarity of amino acids of the pepetids, using Vaxijen-2.0 DPA10201-DPB10101 and DPA10301-DPB10402. Also, among the CD4 + T cell epitopes, 254 5 or 1 can be presented by HLA class II proteins encoded by the alleles of 255 DPA10103-DPB10201 or DPA10201-DPB10501, respectively ( Figure 3B ).

At last, we conducted the docking simulations between the selected T cell epitopes 257 and the HLA molecules using the GalaxyPepDock (35), a server which enables prediction of 3D protein-peptide complex structure interactions from input protein structure and 259 peptide sequence using similar interactions found in the structure database and 260 energy-based optimization. Ten models of each epitope-HLA complex were generated on 261 the basis of minimized energy scores. The scores of estimated accuracy represent the 262 estimated fraction of correctly predicted binding site residues. We docked each of the 263 selected CD8 + T cell epitopes or CD4 + T cell epitopes with the corresponding HLA 264 molecules and scored the pairs. As shown in Table 1 , all of the pairs between the 6 265 selected CD8 + T cell epitopes and the distinct HLA class I molecules scored with 266 estimated accuracy 1. The pairs between the 7 selected CD4 + T cell epitopes and the 267 distinct HLA class II molecules scored with estimated accuracy in a range from 0.792 to 268 0.852, which presents high grade 3D fits of the pairs. The results were further supporting 269 that these epitopes should be strong binders to presented HLA molecules and promising 

Structure of the RNA-dependent RNA polymerase from COVID-19 virus

Structural Basis for

Coupling in the SARS-CoV-2 Replication-Transcription Complex

Coronavirus RNA 481 Proofreading: Molecular Basis and Therapeutic Targeting

Two-amino acids change in 483 the nsp4 of SARS coronavirus abolishes viral replication

Robust SARS-CoV-2-specific T 499 cell immunity is maintained at 6 months following primary infection

SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According 502 to Symptom Severity